Roche's Avastin Fails to Meet Goal of Prostate Study BusinessWeek A combination of the biologic drug, chemotherapy and the prednisone pill didn't extend overall survival compared with treatment with the latter two ...
Pfizer Ends Study on Potential Lung Cancer Drug PharmaLive (press release) (subscription) The company plans on continuing to study the drug candidate in clinical trials focusing on prostate, breast, and other cancers, including types of lung ...
Roche's Avastin fails in prostate cancer study Alibaba News Channel Avastin was being tested in combination with Sanofi-Aventis's chemotherapy drug Taxotere, or docetaxel, and prednisone in men with late stage prostate ...
Roche, Pfizer cancer meds fail trials FiercePharma One of the new studies looked at Sutent as a first-line treatment with chemo in patients with HER-2 negative breast cancer. The other focused on patients ...
Roche's Avastin fails in prostate cancer study Reuters N) reported on Thursday that its cancer drug Sutent had failed tests in breast cancer. [ID:nN11252225] Roche plans to give further details on recent ...
Duo not missing Mary's Walk again (Printed March 12, 2010) Kennebunk-Kennebunkport Post (blog) This year, Hurlbutt, 67, will speak about her experiences with breast cancer before taking to the road in the 12 th annual Mary's Walk in Saco. ...
Cancer Drugs May Not Cure Pfizer Forbes (blog) Just last night, Pfizer said that its targeted kidney cancer drug Sutent had failed in two big trials in breast cancer patients--a potentially much bigger ...
Genentech says Avastin trial did not meet goal CNBC Avastin is approved to treat advanced colorectal, breast, lung and kidney cancer. Genentech said full results from the study will be presented in June at a ...
Avastin disappoints in prostate cancer study Pharma Times The trial did not meet its primary objective of extending overall survival compared to chemotherapy and prednisone alone and the company noted that a ...
